Intercept Pharmaceuticals Inc.

(ICPT) Trade

By |

Profile

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.

Contact Information

Website: www.interceptpharma.com
Email: investors@interceptpharma.com
Main Phone: +1 646 747-1000
Address: 10 Hudson Yards
Address 2: 37th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10001

Issuer Information

Exchange: NGS
CEO: Mark Pruzanski
Employees: 583
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.

Contact Information

Website: www.interceptpharma.com
Email: investors@interceptpharma.com
Main Phone: +1 646 747-1000
Address: 10 Hudson Yards
Address 2: 37th Floor
State: NY
City / Town: New York
Country: US
Postal Code: 10001

Issuer Information

Exchange: NGS
CEO: Mark Pruzanski
Employees: 583
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 37.27 $ -0.12 (-0.32%)
Last Price 37.27 Change $ -0.12 Change % -0.32 Tick N/A
Bid 36.76 Bid Size 400.00 Ask 38.65 Ask Size 1,000.00
Open 37.55 High 38.31 Low 36.74 Prev Close 37.39
Last Trade Volume 424,402 52 Wk Hi 125.00 52 Wk Low 27.03
Market Cap 1.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 32,992,436.00 EPS (TTM) -9.80 PE Ratio -3.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 60
Number of Buys 4 29
Number of Sells 0 31
Net Activity 251170 451095
Last 10 Buys Shares
Mark Pruzanski 1,000
Daniel M. Bradbury 1,000
Keith Gottesdiener 1,000
Luca Benatti 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Srinivas Akkaraju 1,000
Jonathan T. Silverstein 1,000
Srinivas Akkaraju 1,000
Last 10 Sell Shares
Richard Kim 1,000
Lisa Bright 1,000
Sandip S. Kapadia 1,000
Mark Pruzanski 1,000
Rachel McMinn 1,000
David Shapiro 1,000
David Shapiro 1,000
Lisa Bright 1,000
Lisa Bright 1,000
Lisa Bright 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 253 253 253 253
Low Target Price Estimate 57 57 57 57
Mean Target Price Estimate 116.23 116.23 116.23 116.23
Standard Deviation 60.13 60.13 60.13 60.13
Date of Most Recent Estimate 05/31/18 05/22/18 05/22/18 06/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 7 7
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 1 1 1 1
Strong Sell 0 0 1 1
Mean Rec. 2.14 2.14 2.21 2.21